Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Primary objective: To evaluate change from moderate to severe grade of disease in both the group with NEWS-2 <br/ > <br/ > <br/ > <br/ >Timepoint: Time Frame Day 1; Day 3; Day 7; Day 14 <br/ >	Primary objective: To evaluate change from moderate to severe grade of disease in both the group with NEWS-2 <br/ > <br/ > <br/ > <br/ >Timepoint: Time Frame Day 1; Day 3; Day 7; Day 14 <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	Primary objective: To evaluate change from moderate to severe grade of disease in both the group with NEWS-2 <br/ > <br/ > <br/ > <br/ >Timepoint: Time Frame Day 1; Day 3; Day 7; Day 14 <br/ >	Primary objective: To evaluate change from moderate to severe grade of disease in both the group with NEWS-2 <br/ > <br/ > <br/ > <br/ >Timepoint: Time Frame Day 1; Day 3; Day 7; Day 14 <br/ >